According to a survey conducted by the Monetary Authority of Singapore, Singapore's GDP growth rate is expected to be 3.6% in 2024 (previously 2.6%) and 3.1% in the fourth quarter of 2024 (previously 2.2%).China Minerals and Guangxi Iron and Steel have established mining technology companies. The enterprise search APP shows that recently, China National Mining Chain (Guangxi) Mining Technology Co., Ltd. was established, with Ji Wendong as the legal representative and a registered capital of 90 million yuan. Its business scope includes mineral washing and processing, metal ore sales and metal material sales. Enterprise survey shows that the company is jointly owned by China Mineral's China Mineral Resources Group International Supply Chain Co., Ltd. and Guangxi Iron and Steel Group Co., Ltd.According to the monetary authority of singapore survey, economists predict that the core inflation rate will be 1.8% in 2025.
Head of South Korea's senior public official crime investigation department: If the conditions are met, it will seek to arrest Yin Xiyue. The head of South Korea's senior public official crime investigation department said that if the conditions are met, the team will seek to arrest President Yin Xiyue or seek to issue an arrest warrant for him. On Wednesday, when answering questions raised by opposition lawmakers at the National Assembly meeting, Oh Dong-woon indicated that he had the intention to arrest Yin Xiyue.According to a survey conducted by the Monetary Authority of Singapore, Singapore's GDP growth rate is expected to be 3.6% in 2024 (previously 2.6%) and 3.1% in the fourth quarter of 2024 (previously 2.2%).Academician Qiao Jie, Executive Vice President of Peking University, and his party visited Sunflower Pharmaceutical Group. On December 9th, Academician Qiao Jie, Executive Vice President of Peking University, and his party visited the headquarters of Sunflower Pharmaceutical Group for investigation and exchange. At the symposium, Tan Lei, general manager of the strategic management department of Sunflower Pharmaceutical Group, gave a detailed report on the promotion plan of the project "Peking University Medical-Sunflower Pharmaceutical Group Joint Laboratory of Bacterial Enzyme and Innovative Drugs". Sunflower Pharmaceutical Group will join hands with Peking University Medical Center, and the teams of the two sides will cooperate in depth to jointly develop new drugs based on the active substances of traditional Chinese medicine and the discovered important disease targets, promote the transformation of scientific research achievements, deepen the advantageous fields of biotechnology, and help improve the scientific research and innovation ability and technology development level. During the talks, the two sides also conducted in-depth exchanges and discussions on a number of contents.
There is a wave of "restriction on purchases" in the public offering market. The announcement of Huitianfu Fund on December 11th shows that since December 12th, Huitianfu Enhanced Income Bond A has suspended large-scale subscription, large-scale conversion and large-scale fixed investment business, and the amount of single or multiple cumulative subscriptions, conversion and fixed investment in a single fund account per day should not exceed 10 million yuan (inclusive). Recently, the reporter found that there is a "restricted purchase tide" in the public offering market. Whether it is active equity funds, bond funds or QDII funds, many outstanding products have recently announced the suspension of large-scale subscription, and even QDII products have directly "closed the market" and suspended all buying operations. (CSI)President of Japan Life Insurance: I don't think we are behind our competitors in overseas acquisitions, but we are concerned about different countries.Survey by Monetary Authority of Singapore: Economists have lowered Singapore's non-oil domestic export growth forecast from 3.0% to 1.0% in 2024.
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide